Publication | Open Access
Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
80
Citations
34
References
2014
Year
Our study provides pharmacological evidence that CS-6 exhibits potential use in the treatment of COX-2-mediated diseases such as lung cancer.
| Year | Citations | |
|---|---|---|
2011 | 55K | |
2010 | 12.6K | |
2013 | 4.4K | |
2013 | 4K | |
2008 | 2.8K | |
1998 | 2.3K | |
1995 | 1.4K | |
1999 | 961 | |
1999 | 919 | |
1996 | 709 |
Page 1
Page 1